GlaxoSmithKline has said it will not face charges for failing to pay the full cost of its cholesterol-lowering drug Crestor for the first time.
The company said the US Food and Drug Administration required AstraZeneca to pay $1.9 billion (£1.3 billion) in damages to its members who had not yet filed a lawsuit against it.
The $1.9 billion will be reimbursed by the federal government as part of a plan to limit drug price increases.
The announcement by AstraZeneca came as the UK's drug industry faces fierce competition from rival statin drug Crestor, which has caused panic in Europe.
The European Commission, led by Dr Martin Bu purchaser and AstraZeneca, has been working to set up new drug giants to lower the price of cholesterol drugs.
They include Novartis, Bristol-Myers Squibb, Bayer and Eli Lilly.
GlaxoSmithKline said it planned to start a process of finalising the agreements and will submit its data to the US Food and Drug Administration, which will make them available to the public.
But its spokesman, Professor Steve Smith, said: "It's very difficult to say we will pay for a drug we don't have to pay for."
Glaxo's chief executive, Peter Shulman, said he would appeal the decision.
In a statement on Tuesday, Glaxo said: "We believe that AstraZeneca's conduct in the US market and other countries' practices have caused substantial harm to millions of patients."
It said it would seek the US Court of Arbitration forSingapore's decision if it were to seek damages for harm that had been incurred by the company's executives.
In a statement, AstraZeneca said the company would pay $1.9 billion (£1.3 billion) in damages to its members who had not yet filed a lawsuit against AstraZeneca.
The decision was made after a number of investigations into the conduct of AstraZeneca's executives.
AstraZeneca's CEO, Andrew Witty, said: "The decision to pay AstraZeneca is a clear sign that it is not going to do the right thing. It is one of the most dramatic actions we have taken in recent times, as a result of the huge numbers of prescriptions being dispensed at different dosages."
The company said it will appeal the decision.
The UK's largest pharmaceutical firm, Mylan Pharmaceuticals, said it was planning to launch a similar cholesterol drug called Crestor on a global stage in early 2007.
The UK's biggest drugmaker, AstraZeneca, said it had "certain regulatory and legal obligations to pay for this company's conduct and has taken steps to ensure that this is not a future product for the company and to pay for any damages arising out of this conduct."
The company also agreed to pay an extra $370 million (£180 million) to resolve litigation regarding the conduct of its sales force.
The company said the decision was a major blow to the industry, where it has faced pressure from regulators, as well as some critics of the industry.
Reuters/Carrie EderShare:Share in this article:
Copy emailCopy image
Copy web addressLoading...
Copy passwordShare
Copy linkShowing 1,000 to 1,499 of this article
Copyright 2024. This content is provided by the author/author. Read our to find out more about this article and how to post it. It is for informational purposes only. This article is intended to increase awareness about the risks associated with the practice of medicine.
Before you start taking Crestor, talk with your doctor about whether you have any of the following conditions or if you should consider taking it.
Before you take Crestor, make sure your doctor knows:
Stopping taking Crestor
April 19, 2010— --For the last five years, the Canadian pharmaceutical company Crestor has been struggling. The company said this year that it expects to lose $1 billion in sales in 2009 and expects to earn $1.5 billion in annual profits from the transaction, as well as $2 billion in revenue from sales and marketing.
Crestor said it is taking the $1 billion in proceeds from the transaction to finance its research and development. Crestor has also been paying millions of dollars in dividends to its shareholders, which the company is also trying to offset.
The company said in a statement, "We believe it is important for Crestor to continue to perform well in the therapeutic areas of our business."
It is also planning to have sales for the first two years of its life in order to pay back the debt it is owed. Crestor's sales will be used to develop and commercialize its new products and to manufacture and sell the existing products that it has made, with the goal of reducing costs.
The company said Crestor will also have access to the market through sales and marketing. The company has also planned to have sales representatives in Toronto and other markets to provide the marketing and sales representatives to the public. It will also have a second-phase presence in the United States.
The company said it expects to make $2.3 billion in sales in 2009. It expects the company to make $2.5 billion in sales this year and $2.6 billion in 2009.
The company is still in an enviable position because Crestor's sales have gone up about three percent this year. Crestor is looking to reduce its expenses, which will be reduced by $1 billion in 2008. Crestor is in a similar position to the company in terms of sales.
Crestor also is experiencing financial distress, especially from its recently announced loss of tax revenue. The company expects the tax losses from the company to grow by about 6 percent in 2009.
The company is also facing a $2 billion tax bill from the Canadian International Pharmaceutical Corporation, which is expected to reduce the tax rate on its shares by about 5 percent.
The company is also having difficulty paying the debt it has to the government for the tax overhaul it is facing. The government recently lifted a new payment schedule for the company that would allow it to continue its growth initiatives.
The company said Crestor will be responsible for paying the remaining debt. It will also be responsible for paying the remaining interest on the company's stock.
Crestor's financial results will be in line with the results of the tax bill in 2009. The company said it has achieved full-year results for the year and will also be able to reduce its debt.
Crestor has also been working on a number of acquisitions, including the company's planned acquisition of a new manufacturing facility, which will be able to generate revenue to cover the restructuring costs. Crestor will also have a new research and development facility in Canada.
Crestor is also working on a number of acquisitions, including the acquisition of a new manufacturing facility in Canada, which will be able to generate revenue to cover the restructuring costs.
The company's stock price, which was higher than analysts had expected, will remain at the high levels it had been in before the end of the year. Crestor's stock has fallen to $13.00 at the end of this year.
The company was unable to comment on the results of the tax bill in 2009. Crestor's stock has fallen from $13.00 at the end of last year.
For the latest on the company's finances and the tax implications of the $2 billion it is facing in 2009, the Securities and Exchange Commission can contact a senior officer, information technology director or sales representative, or a special analyst, at 678-514-2470 or (6) 678-514-2470, via email or phone, Monday, through Friday, 8 a.m., to receive a comment.
The Securities and Exchange Commission is investigating whether the company is likely to have to raise its dividend as planned. Crestor said the company will pay a dividend to shareholders of $2.5 million a year in 2011. The company said it expects to pay the dividend in the next two years to shareholders as well as other shareholders.Crestor is also facing a $2 billion tax bill from the Canadian International Pharmaceutical Corporation, which is expected to reduce the tax rate on its shares by about 5 percent.Crestor 10mg Tablet belongs to a group of medicines called statins. It is used to lower cholesterol and reduce the risk of heart disease. Cholesterol is a fatty substance that is required in order to survive. It is present in all tissues and can be used as a tool to lower cholesterol and improve cholesterol levels. You are required to speak with your doctor regarding the use of Crestor 10mg Tablet for low cholesterol and possible side effects. It is important to talk with your doctor as soon as possible if you are taking any medication for high cholesterol or low cholesterol.
Crestor 10mg Tablet is suitable for adults and adolescents aged 10 years and older. It is not suitable for children. Crestor 10mg Tablet is not suitable for individuals who are hypersensitive to, or have certain medical conditions, such as liver cirrhosis. It should not be taken if you are allergic to Crestor 10mg Tablet or any other ingredients in the medication. Inform your doctor if you have any history of muscle diseases or liver problems. You must inform your doctor if you are taking any other medicines, including supplements or herbal products that contain other statins, before starting treatment with Crestor 10mg Tablet.
Before starting treatment with Crestor 10mg Tablet, your doctor should be informed about all the medications you are taking, including prescription and non-prescription medications. Crestor 10mg Tablet should not be taken if you are allergic to Crestor 10mg Tablet or any other components. You should tell your doctor if you are taking any of the medications listed below.
Crestor 10mg Tablet may interact with some medications. Do not take this medicine if you are taking warfarin (atsoncalb & martin). It could cause problems with memory, driving and operate machinery. Before taking Crestor 10mg Tablet inform your doctor if you are taking any of the medications listed below. Some medications may also increase your blood pressure. Before you start treatment with Crestor 10mg Tablet tell your doctor about all the medications you are taking, especially any of the medications listed below. Some medications can increase the chance of muscle disease or liver problems. Before you start treatment with Crestor 10mg Tablet tell your doctor if you are taking any of the medications listed below. Some medications can increase your blood pressure. Crestor 10mg Tablet should not be taken if you are taking any of the medications listed below. Some medications may increase the chance of muscle disease or liver problems. Tell your doctor if you are taking any of the medications listed below.